Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose.

López-Marte, Paola; Soto-González, Alondra; Ramos-Tollinchi, Lizzie; Torres-Jorge, Stephan; Ferre, Mariana; Rodríguez-Martinó, Esteban; Torres, Esther A; Sariol, Carlos A

López-Marte, Paola; Soto-González, Alondra; Ramos-Tollinchi, Lizzie; Torres-Jorge, Stephan; Ferre, Mariana; Rodríguez-Martinó, Esteban; Torres, Esther A; Sariol, Carlos A.

Afiliación

López-Marte P; Gastroenterology Research, School of Medicine, University of Puerto Rico, San Juan 00925, Puerto Rico.
Soto-González A; Gastroenterology Research, School of Medicine, University of Puerto Rico, San Juan 00925, Puerto Rico.
Ramos-Tollinchi L; Gastroenterology Research, School of Medicine, University of Puerto Rico, San Juan 00925, Puerto Rico.
Torres-Jorge S; Gastroenterology Research, School of Medicine, University of Puerto Rico, San Juan 00925, Puerto Rico.
Ferre M; Department of Microbiology and Medical Zoology, School of Medicine, University of Puerto Rico, San Juan 00925, Puerto Rico.
Rodríguez-Martinó E; Division of Gastroenterology, School of Medicine, University of Puerto Rico, San Juan 00925, Puerto Rico.
Torres EA; Gastroenterology Research, School of Medicine, University of Puerto Rico, San Juan 00925, Puerto Rico.
Sariol CA; Division of Gastroenterology, School of Medicine, University of Puerto Rico, San Juan 00925, Puerto Rico.

Vaccines (Basel) ; 10(8)2022 Aug 11.

Article en En | MEDLINE | ID: mdl-36016189